According to the company, HEK293 cells are the most widely used human cell line in biotechnology industry and the only human cell line used for the bioproduction of an FDA approved biopharmaceutical drug.
Pierre-Alain Girod, CSO of Selexis, said: “This combined program will be highly desirable to biotech companies needing the rapid development of a high performance cell line expressing proteins with human glycosylation patterns. This new platform will be a viable option to our CHO program for more difficult to express proteins.”